<?xml version='1.0' encoding='utf-8'?>
<document id="29228815"><sentence text="Acute and Subchronic Toxicity Studies of Aqueous Extract of Desmodium adscendens (Sw) DC." /><sentence text="Extracts of Desmodium adscendens (Sw) DC are used for the treatment of various diseases but limited toxicological evaluations have been done on the medicinal plant" /><sentence text=" This study investigates toxicity effects of the leave extract of D adscendens, and the possibility of drug-drug interaction of the plant extract when co-administered with other drugs" /><sentence text=" Oral administrations of leaf extract of D adscendens to white Wistar rats in an acute toxicity studies allowed the estimation of an LD50 (median lethal dose) value of 1122 mg/kg body weight" /><sentence text=" In a subchronic toxicity studies, the plant extract caused a decrease in zoxazolamine paralysis time and prevented thiopentone from causing sleep in test animals compared to controls"><entity charOffset="74-86" id="DDI-PubMed.29228815.s5.e0" text="zoxazolamine" /><entity charOffset="116-127" id="DDI-PubMed.29228815.s5.e1" text="thiopentone" /><pair ddi="false" e1="DDI-PubMed.29228815.s5.e0" e2="DDI-PubMed.29228815.s5.e0" /><pair ddi="false" e1="DDI-PubMed.29228815.s5.e0" e2="DDI-PubMed.29228815.s5.e1" /></sentence><sentence text=" Overall, the results are consistent with the plant extract being safe at the doses administered in humans" /><sentence text=" However, the induction of the CYP enzymes is an indication of a possible drug interaction when the plant extract is co-administered with other drugs" /><sentence text="" /></document>